Dr. Beisswenger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
16 Cavendish Ct
Journey Biosciences
Lebanon, NH 03766Phone+1 603-996-1576- Is this information wrong?
Summary
- Dr. Paul Beisswenger is an endocrinologist in Lebanon, NH. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 53 years. He specializes in diabetes and after many years of research on diabetic complications, he has started a company that offers a blood test that predicts risk of diabetic kidney disease.
Education & Training
- University of Pennsylvania Health SystemChief Residency, Internal Medicine, 1969 - 1970
- Harvard Medical SchoolPost-Doctoral Fellowship, diabetes/biochemistry, 1967 - 1969
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1965 - 1967
- Perelman School of Medicine at the University of PennsylvaniaClass of 1964
Certifications & Licensure
- NH State Medical License 1975 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Publications & Presentations
PubMed
- Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study.Clare B Kelly, Harsha Karanchi, Jeremy Y Yu, Misti J Leyva, Alicia J Jenkins, Alison J Nankervis, Kristian F Hanssen, Satish K Garg, James A Scardo, Samar M Hammad, Ch...> ;Journal of Diabetes Research. 2023 Jan 1
- 25 citationsAdvanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes.Juraj Koska, Hertzel C Gerstein, Paul J Beisswenger, Peter D Reaven> ;Diabetes Care. 2022 Mar 1
- Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Ca...Juraj Koska, Hertzel C Gerstein, Paul J Beisswenger, Peter D Reaven> ;Diabetes Care. 2022 Jun 2
- Join now to see all
Press Mentions
- Precision Diabetes, LLC, Presents Data on Novel, Predictive Tests for Diabetes Complications at American Diabetes Association (ADA) Research Symposium: Advancing Precision Diabetes MedicineOctober 8th, 2019
- Johnson & Johnson Innovation Announces Winners of the Singapore QuickFire Challenge in Collaboration with ETPL and SMARTSeptember 22nd, 2017
Grant Support
- Glycation And MU Dicarbonyls In Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- Enzymatic Controls Of Nonenzymatic GlycationNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
Industry Relationships
- Chief Scientific Officer, Journey Biosciences2012 - 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: